cabergoline has been researched along with Galactorrhea in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Bruehlman, RD; McKittrick, C; Winters, S | 1 |
Castillo-Huerta, E; Garibay-Valencia, M; Mirabent-González, F | 1 |
Bronstein, MD; Espinosa, E; Glezer, A; Greenman, Y; Mendoza, V; Mercado, M; Popovic, V; Shimon, I; Sosa, E; Tirosh, A | 1 |
Dhanjal, MK; Knight, M; Lambert, K; McCance, DR; Rees, K; Seed, PT; Williamson, C | 1 |
Acharya, SV; Bandgar, TR; Gopal, RA; Joshi, SR; Menon, PS; Shah, NS | 1 |
Bianchi, A; Carrozza, C; D'Ercole, M; Della Pepa, GM; Doglietto, F | 1 |
Arlt, S; Drillich, M; Fischer-Tenhagen, C; Heuwieser, W; Reinecke, A | 1 |
Coppola, A; Cuomo, MA | 1 |
1 review(s) available for cabergoline and Galactorrhea
Article | Year |
---|---|
[Prolactinoma in the male. Physiopathological, clinical, and therapeutic features].
Topics: Cabergoline; Cranial Irradiation; Dopamine Agonists; Erectile Dysfunction; Ergolines; Galactorrhea; Gynecomastia; Humans; Hyperprolactinemia; Hypophysectomy; Infertility, Male; Libido; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 1998 |
1 trial(s) available for cabergoline and Galactorrhea
Article | Year |
---|---|
[Clinical comparision of alpha dihydroergocryptine against cabergoline in the treatment of the fibrocystic mastopathy].
Topics: Adolescent; Adult; Cabergoline; Dihydroergocryptine; Ergolines; Female; Fibrocystic Breast Disease; Galactorrhea; Gastrointestinal Diseases; Headache; Humans; Mastodynia; Middle Aged; Prolactin; Prospective Studies; Treatment Outcome; Young Adult | 2013 |
6 other study(ies) available for cabergoline and Galactorrhea
Article | Year |
---|---|
Galactorrhea: Rapid Evidence Review.
Topics: Cabergoline; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin | 2022 |
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Child; Ergolines; Female; Galactorrhea; Headache; Hormone Antagonists; Humans; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Sexual Dysfunction, Physiological; Treatment Outcome; Tumor Burden; Vision Disorders; Young Adult | 2016 |
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
Topics: Adenoma; Adult; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cesarean Section; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Incidence; Pituitary Neoplasms; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Neoplastic; Premature Birth; Prolactinoma; Prospective Studies; Stillbirth; United Kingdom; Vision Disorders; Young Adult | 2017 |
Clinical profile and long term follow up of children and adolescents with prolactinomas.
Topics: Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Male; Pregnancy; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
Two diagnostic pitfalls mimicking a prolactin-secreting microadenoma.
Topics: Adenoma; Adult; Antineoplastic Agents; Cabergoline; Diagnosis, Differential; Diagnostic Errors; Ergolines; Female; Galactorrhea; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Menstruation Disturbances; Pituitary Neoplasms; Prolactin | 2010 |
[Inappropriate lactation syndrome in goats--case collection and experiences with mastectomy].
Topics: Animals; Cabergoline; Dopamine Agonists; Ergolines; Female; Galactorrhea; Goat Diseases; Goats; Mastectomy; Recurrence; Surgical Flaps; Treatment Outcome | 2011 |